Last update 08 May 2025

INR-102

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
Target
PSMA
Action
modulators
Mechanism
PSMA modulators(Prostate-specific membrane antigen modulators)
Therapeutic Areas
NeoplasmsUrogenital Diseases
Active Indication
PSMA-Positive Castration-Resistant Prostatic CancerMetastatic castration-resistant prostate cancerProstatic Cancer
Inactive Indication-
Originator Organization
Yunnan Baiyao Group Co., Ltd.Yunnan Baiyao Group Co., Ltd.
Active Organization
Yun He Yi Yao （ Tian Jin ） You Xian Gong SiYunnan Baiyao Group Co., Ltd.Yunnan Baiyao Group Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with INR-102
CTR20251605
/ Not yet recruitingPhase 1/2
一项评价INR102注射液在前列腺特异性膜抗原（PSMA）阳性的转移性去势抵抗性前列腺癌（mCRPC)患者中的安全性、耐受性、药代动力学、辐射剂量学和初步疗效的多中心、开放、非随机的Ⅰ/Ⅱa期临床试验
[Translation] A multicenter, open-label, non-randomized phase I/IIa clinical trial to evaluate the safety, tolerability, pharmacokinetics, radiation dosimetry, and preliminary efficacy of INR102 injection in patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC)
100 Clinical Results associated with INR-102
Login to view more data
100 Translational Medicine associated with INR-102
Login to view more data
100 Patents (Medical) associated with INR-102
Login to view more data
100 Deals associated with INR-102
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
PSMA-Positive Castration-Resistant Prostatic CancerPhase 2
China
Yun He Yi Yao （ Tian Jin ） You Xian Gong Si
24 Apr 2025
Metastatic castration-resistant prostate cancerIND Approval
China
Yun He Yi Yao （ Tian Jin ） You Xian Gong Si
07 Apr 2025
Prostatic CancerPreclinical
China
Yunnan Baiyao Group Co., Ltd.Yunnan Baiyao Group Co., Ltd.
16 May 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free